The importance of CTLA-4 polymorphism and human leukocyte antigen genotype for the induction of diabetes-associated cytokine response in healthy school children

Pediatric Diabetes

Volumn 8, Issue 4, 2007, Pages 185-192

  Jonson, Carl Oscar ^a   Lernmark, Åke ^b   Ludvigsson, Johnny ^a   Rutledge, Elizabeth A ^b   Hinkkanen, Ari ^c   Faresjö, Maria ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

CTLA 4; Cytokines; HLA; SNP; Type 1 diabetes mellitus

Indexed keywords

ADENINE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE 65; GUANINE; HEAT SHOCK PROTEIN 60; HLA ANTIGEN; HLA DQ ANTIGEN; INTERLEUKIN 4;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETOGENESIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CHAPERONIN 60; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HLA-DQ ANTIGENS; HUMANS; INSULIN ANTIBODIES; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 34547128874     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00245.x     Document Type: Article

References (44)

1. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996: 17: 323-329.
2. Field AC, Bloch MF, Bellon B. Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells. J Autoimmun 2003: 21: 201-212.
3. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994: 331: 1428-1436 (Review).
4. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-377 (Review).
5. Lobnig BM, Chantelau E, Vidgren G et al. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: Evidence for possible mutual exclusion of both diseases. Diabetes Metab 2002: 28: 217-221.
6. Pundziute-Lyckå A, Dahlquist A, Nyström L et al. The incidence of type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983 to 1998. Diabetologia 2002: 45: 783-791.
7. E isenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986: 314: 1360-1368 (Review).
8. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978: 1: 57-60.
9. Hyöty H, Hiltunen M, Reunanen A et al. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia 1993: 36: 1303-1308.
10. Ray CG, Palmer JP, Crossley JR, Williams RH. Coxsackie B virus antibody responses in juvenile-onset diabetes mellitus. Clin Endocrinol (Oxf) 1980: 12: 375-378.
11. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994: 94: 2125-2129.
12. Niklasson B, Heller KE, Schonecker B et al. Development of type 1 diabetes in wild bank voles associated with islet autoantibodies and the novel Ljungan virus. Int J Exp Diabesity Res 2003: 4: 35-44.
13. Elias D, Reshef T, Birk OS et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A 1991: 88: 3088-3091.
14. Cohen IR. Peptide therapy for type I diabetes: The immunological homunculus and the rationale for vaccination. Diabetologia 2002: 45: 1468-1474.
15. Danke N.A. Koelle D.M. Yee C. Beheray S. Kwok W.W. Autoreactive T cells in healthy individuals. J Immunol 2004: 172: 5967-5972.
16. Karlsson MG, Lawesson SS, Ludvigsson J. Th1-like dominance in high-risk first-degree relatives of type I diabetic patients. Diabetologia 2000: 43: 742-749.
17. Karlsson MG, Ludvigsson J. Peptide from glutamic acid decarboxylase similar to Coxsackie B virus stimulates IFN-gamma mRNA expression in Th1-like lymphocytes from children with recent-onset insulin-dependent diabetes mellitus. Acta Diabetol 1998: 35: 137-144.
18. Karlsson Faresjo MG, Ernerudh J, Ludvigsson J. Cytokine profile in children during the first 3 months after the diagnosis of type 1 diabetes. Scand J Immunol 2004: 59: 517-526.
19. Wang XB, Kakoulidou M, Qiu Q et al. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis. Genes Immun 2002: 3: 46-49.
20. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003: 423: 506-511.
21. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997: 158: 1989-1993.
22. Fallarino F, Grohmann U, Vacca C et al. CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8(+) dendritic cells. J Immunol 2002: 169: 1182-1188.
23. Grohmann U, Orabona C, Fallarino F et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002: 3: 1097-1101.
24. Read S, Malmstrom V, Powrie F. CytotoxicT lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000: 192: 295-302.
25. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996: 5: 1075-1080.
26. Donner H, Rau H, Walfish PG et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 143-146.
27. Marron MP, Raffel LJ, Garchon HJ et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997: 6: 1275-1282.
28. Jonson CO, Hedman M, Karlsson Faresjo M et al. The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children. Clin Exp Immunol 2006: 145: 48-55.
29. Wicker LS, Chamberlain G, Hunter K et al. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J Immunol 2004: 173: 164-173.
30. Schloot NC, Meierhoff G, Karlsson Faresjo M et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003: 21: 365-376.
31. Heward JM, Allahabadia A, Armitage M et al. The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999: 84: 2398-2401.
32. Sjöroos M, IitiäA, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. BioTechniques 1995: 18: 870-877.
33. Nejentsev S, Sjöroos M, Soukka T et al. Population based genetic screening for type 1 diabetes risk in Finland: Selective genotyping of the markers in the HLA-DQB1, -DQA and -DRB1 loci. Diabet Med 1999: 16: 985-992.
34. Laaksonen M, Pastinen T, Sjoroos M et al. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol 2002: 122: 140-145.
35. Wahlberg J, Fredriksson J, Vaarala O, Ludvigsson J. Vaccinations may induce diabetes-related autoantibodies in one-year-old children. Ann N Y Acad Sci 2003: 1005: 404-408.
36. Holmberg H, Vaarala O, Falth-Magnusson K, Ludvigsson J. Induction of diabetes-related autoantibodies below cutoff for "positivity"in young nondiabetic children. Ann N Y Acad Sci 2003: 1005: 269-274.
37. Lühder F, Höglund P, Allison JP, Benoist C, Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 1998: 187: 427-432.
38. Tivol EA, Boyd SD, Mckeon S et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 1997: 158: 5091-5094.
39. Elias D, Meilin A, Ablamunits V et al. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 1997: 46: 758-764.
40. Karlsson Faresjo MG, Ludvigsson J. Diminished Th1-like response to autoantigens in children with a high risk of developing type 1 diabetes. Scand J Immunol 2005: 61: 173-179.
41. Karlsson Faresjo M, Vaarala O, Thuswaldner S et al. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes. Diabetes Metab Res Rev 2006: 22: 462-470.
42. Hedman M, Ludvigsson J, Faresjo MK. Nicotinamide reduces high secretion of IFN-gamma in high-risk relatives even though it does not prevent type 1 diabetes. J Interferon Cytokine Res 2006: 26: 207-213.
43. Gribben JG, Freeman GJ, Boussiotis VA et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995: 92: 811-815.
44. Vasu C, Prabhakar BS, Holterman MJ. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. J Immunol 2004: 173: 2866-2876.